DLB as reported
Dolby Laboratories, Inc. reported $1.26B of revenue over the trailing twelve months. 10 reported series are charted on this page, each one as filed.
$1.26B
Revenue, trailing twelve months · to Q3 2022 · every figure below is as filed, with no scoring applied
- Net Income
- $244M
Net Income · −5.1% year on year · trailing twelve months to Q2 2026
- Free Cash Flow
- $301M
Free Cash Flow · −23% year on year · trailing twelve months to Q2 2026
- EPS
- $2.53
EPS · −4.2% year on year · trailing twelve months to Q2 2026
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | $1.26B | n/a | Q3 2022 · 15 quarters behind |
| Net Income | $244M | −5.1% | Q2 2026 |
| EPS | $2.53 | −4.2% | Q2 2026 |
| Gross Margin | 89% | n/a | Q3 2022 · 15 quarters behind |
| Op Margin | 17% | n/a | Q3 2022 · 15 quarters behind |
| Net Margin | 16% | n/a | Q3 2022 · 15 quarters behind |
| ROE | 9.6% | n/a | Q2 2026 |
| ROA | 7.8% | n/a | Q2 2026 |
| Free Cash Flow | $301M | −23% | Q2 2026 |
| P/E | 25.7 | n/a | today |
Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.
Dolby Laboratories, Inc. (DLB) - Revenue & ProfitRevenue & ProfitDolby Laboratories, Inc. (DLB)
Revenue (TTM)Net Income (TTM)
Powered byryufin.com
Specialty Business Services
Ranks #3 of 18 by Smart Score